Literature DB >> 3800651

Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis.

R N Stephan, T S Kupper, A S Geha, A E Baue, I H Chaudry.   

Abstract

To determine whether hemorrhage without major tissue trauma can itself produce immunosuppression, the effect of hemorrhage on the lymphocyte response to T-cell mitogen in endotoxin-resistant C3H/HEJ mice was measured. The mice were bled to achieve a mean blood pressure of 35 mm Hg, maintained at that level for one hour, and then adequately resuscitated. On days 1 through 10 thereafter, the proliferative responses of the splenocytes to concanavalin A were measured and allogeneic mixed lymphocyte reaction was performed. The proliferative responses to mitogen stimulation as well as the results of mixed lymphocyte reaction studies indicated that marked immunosuppression occurred at day 1. Immunosuppression persisted for at least five days following hemorrhage, as evidenced by mitogen stimulation assay. Another group of mice was subjected to sepsis three days after hemorrhage and resuscitation. The mortalities in the sham-hemorrhage and hemorrhage groups following sepsis were 58% and 100%, respectively. Thus, a significant depression of cellular immunity occurred following simple hemorrhage despite adequate resuscitation, and this immunosuppression enhanced the susceptibility to sepsis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3800651     DOI: 10.1001/archsurg.1987.01400130068010

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  40 in total

Review 1.  Gender dimorphism in immune responses following trauma and hemorrhage.

Authors:  Yukihiro Yokoyama; Martin G Schwacha; T S Anantha Samy; Kirby I Bland; Irshad H Chaudry
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  The influence of laparoscopy on lymphocyte subpopulations in the surgical patient.

Authors:  V L Vallina; J M Velasco
Journal:  Surg Endosc       Date:  1996-05       Impact factor: 4.584

3.  Evidence of a plasma-mediated "window" of immunodeficiency in rats following trauma.

Authors:  C D Mills; M D Caldwell; D S Gann
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

Review 4.  The future of murine sepsis and trauma research models.

Authors:  Philip A Efron; Alicia M Mohr; Frederick A Moore; Lyle L Moldawer
Journal:  J Leukoc Biol       Date:  2015-06-01       Impact factor: 4.962

5.  Activation of AMPK enhances neutrophil chemotaxis and bacterial killing.

Authors:  Dae Won Park; Shaoning Jiang; Jean-Marc Tadie; William S Stigler; Yong Gao; Jessy Deshane; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

Review 6.  The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients.

Authors:  Nicholas S Ward; Brian Casserly; Alfred Ayala
Journal:  Clin Chest Med       Date:  2008-12       Impact factor: 2.878

7.  Defective macrophage antigen presentation following haemorrhage is associated with the loss of MHC class II (Ia) antigens.

Authors:  A Ayala; M M Perrin; I H Chaudry
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

8.  The release of transforming growth factor-beta following haemorrhage: its role as a mediator of host immunosuppression.

Authors:  A Ayala; D R Meldrum; M M Perrin; I H Chaudry
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

9.  Pneumonia in the surgical intensive care unit. Immunologic keys to the silent epidemic.

Authors:  W Naziri; W G Cheadle; J D Pietsch; S Appel; H C Polk
Journal:  Ann Surg       Date:  1994-06       Impact factor: 12.969

10.  CpG-ODN and MPLA prevent mortality in a murine model of post-hemorrhage-Staphyloccocus aureus pneumonia.

Authors:  Antoine Roquilly; Laetitia Gautreau; Jean Pierre Segain; Pierre de Coppet; Véronique Sebille; Cédric Jacqueline; Jocelyne Caillon; Gilles Potel; Corinne Lejus; Régis Josien; Karim Asehnoune
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.